We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




MRI Technology Designed for Diagnosing Painful Back Disorder

By MedImaging International staff writers
Posted on 06 Oct 2014
Print article
A new imaging technique used to identify biomarkers could indicate which patients have a painful, degenerative back condition is under development.

An interdisciplinary research team in the Cedars-Sinai Biomedical Imaging Research Institute (Los Angeles, CA, USA) department of biomedical sciences, Regenerative Medicine Institute and department of surgery received a grant from the US National Institutes of Health (NIH; Bethesda, MD, USA) to develop the technology.

Biomarkers are specific body substances, such as body fluids or fluids that can indicate specific health conditions. When noninvasive imaging modalities, such as magnetic resonance imaging (MRI), can identify exactly where the biomarkers are, researchers may alleviate the need for painful and invasive diagnostic procedures, and in the future, provide targeted, stem cell-based therapies to patients with the condition.

More than 85% of people in the United States alone suffer from low back pain, much of which is caused by intervertebral disc degeneration. Disc degeneration is a progressive condition, resulting in chronic pain in the back and neck. For some patients, degeneration can occur long before pain sets in, presenting symptoms, while others are affected almost immediately.

As described April 2014 in an article in the journal Magnetic Resonance in Medicine, identifying the exact disc that is the source of pain by employing the most sophisticated imaging techniques may save patients from painful and invasive diagnostic procedures, such as procedures in which physicians inject a contrast agent or non-toxic dye into patients’ spinal discs.

“The goal of our institute is to develop and apply novel imaging techniques that translate to clinical significance,” said Debiao Li, PhD, director of the Biomedical Imaging Research Institute, corresponding author of the article and a co-principal investigator on the NIH grant. “This imaging technology may allow us to do just this. By mapping a patient’s lower spinal region, we can identify the discs causing discomfort, which allows physicians to then treat accordingly.”

In the study, investigators developed various imaging techniques using MRI scanning, which can identify specific biomarkers to potentially provide a noninvasive diagnostic approach to intervertebral disc degeneration. The application, which has been evaluated on patients and in the laboratory, enabled researchers to exactly target the origin of pain and monitor the progression of each patient’s condition.

With this imaging technique, investigators in the Regenerative Medicine Institute are trying to generate a stem cell-based therapeutic agent for patients suffering from the degenerative disorder. “Our research team is interested in the role of stem cells in this disease and how we can utilize these cells to regenerate the disc and turn it back into a functional tissue,” said Dan Gazit, PhD, co-principal investigator on the grant and director of the skeletal regeneration and stem cell therapy laboratory in the department of surgery, the skeletal program in the Regenerative Medicine Institute and the molecular- and micro-imaging core facility. “Using this novel imaging technique, we will be able to evaluate the effect of our future stem cell therapies on back pain.”

Hyun Bae, MD, medical director of orthopedic spine surgery and director of spine education, who is co-investigator of the study, said, “By understanding where the source of pain comes from, physicians can better utilize surgical and non-surgical treatments to help patients live a more normal lifestyle.”

Related Links:

Cedars-Sinai Biomedical Imaging Research Institute


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Color Doppler Ultrasound System
DRE Crystal 4PX
New
X-Ray Detector
FDR-D-EVO III
New
Silver Member
Mobile X-Ray Barrier
Lead Acrylic Mobile X-Ray Barriers

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

General/Advanced Imaging

view channel
Image: The CIARTIC Move self-driving mobile C-arm has received FDA clearance (Photo courtesy of Siemens)

Self-Driving Mobile C-Arm Reduces Imaging Time during Surgery

Intraoperative imaging faces significant challenges due to staff shortages and the high demands placed on surgical teams in the operating room (OR). A common challenge during many OR procedures is the... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.